Tag: managed service
-
The Register: UK threatens £100K-a-day fines under new cyber bill
Source URL: https://www.theregister.com/2025/04/01/uk_100k_fines_csr/ Source: The Register Title: UK threatens £100K-a-day fines under new cyber bill Feedly Summary: Tech secretary reveals landmark legislation’s full details for first time The UK’s technology secretary revealed the full breadth of the government’s Cyber Security and Resilience (CSR) Bill for the first time this morning, pledging £100,000 ($129,000) daily fines…
-
AWS News Blog: AWS Weekly Roundup: Amazon Bedrock, Amazon QuickSight, AWS Amplify, and more (March 31, 2025)
Source URL: https://aws.amazon.com/blogs/aws/aws-weekly-roundup-amazon-bedrock-amazon-quicksight-aws-amplify-and-more-march-31-2025/ Source: AWS News Blog Title: AWS Weekly Roundup: Amazon Bedrock, Amazon QuickSight, AWS Amplify, and more (March 31, 2025) Feedly Summary: It’s AWS Summit season! Free events are now rolling out worldwide, bringing our cloud computing community together to connect, collaborate, and learn. Whether you prefer joining us online or in-person, these…
-
Cloud Blog: AlloyDB for PostgreSQL: Two years of innovation and industry leadership
Source URL: https://cloud.google.com/blog/products/databases/reflecting-on-two-years-of-alloydb/ Source: Cloud Blog Title: AlloyDB for PostgreSQL: Two years of innovation and industry leadership Feedly Summary: Two years ago, on a mission to redefine enterprise-grade databases we released AlloyDB for PostgreSQL in production. We saw the immense popularity and flexibility of PostgreSQL — a database developers love for being open-source — and…
-
Cloud Blog: Accelerating AI in healthcare using NVIDIA BioNeMo Framework and Blueprints on GKE
Source URL: https://cloud.google.com/blog/products/ai-machine-learning/accelerate-ai-in-healthcare-nvidia-bionemo-gke/ Source: Cloud Blog Title: Accelerating AI in healthcare using NVIDIA BioNeMo Framework and Blueprints on GKE Feedly Summary: The quest to develop new medical treatments has historically been a slow, arduous process, screening billions of molecular compounds across decade-long development cycles. The vast majority of therapeutic candidates do not even make it…